A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma

Stopped Study terminated due to low enrollment making it unlikely to meet recruitment goals.

Conditions

• Unresectable Intrahepatic Cholangiocarcinoma

Interventions

• DRUG: gemcitabine
• DRUG: Cisplatin
• DRUG: Conventional TACE (transarterial chemoembolization) with Doxorubicin/Mitomycin-C

Sponsor

Yale University